Showing 41 - 60 results of 107 for search '"Down Syndrome"', query time: 0.06s Refine Results
  1. 41

    Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review by Charlotte Jacob, Marleen Tollenaere, Hanane Kachar, Marie-Claude Potier, Peter Paul De Deyn, Debby Van Dam

    Published 2025-01-01
    “…People with Down Syndrome (DS) are at high risk of developing Alzheimer's disease dementia (AD) and cerebral amyloid angiopathy, which is a critical factor contributing to dementia in sporadic AD. …”
    Get full text
    Article
  2. 42

    Four Cases of Myeloproliferative Disorders Associated With Down Syndrome: Distinguishing ML-DS From TAM-DS by Kévin Boumeghar, Sylvie Daliphard, Nimrod Buchbinder, Catherine Boutet, Dominique Penther, Pascaline Etancelin, Julien Bourgain, Gérard Buchonnet, Elsa Bera, Victor Bobée

    Published 2024-01-01
    “…Down syndrome (DS) is defined by an extra copy of chromosome 21 and confers an increased susceptibility to hematological disorders. …”
    Get full text
    Article
  3. 43
  4. 44

    Denying to Embracing: A Mother's Path to Acceptance, Love, and Resilience in Raising a Child with Down Syndrome by Alyanna V. Zabala, Araceli C. Doromal

    Published 2025-01-01
    Subjects: “…Special education, Down syndrome, Mothers, Phenomenology, Philippines…”
    Get full text
    Article
  5. 45

    Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome. by Makiko Shinomoto, Chisen Takeuchi, Harutsugu Tatebe, Fukiko Kitani-Morii, Takuma Ohmichi, Yuzo Fujino, Kanako Menjo, Naoto Terada, Miho Osako, Yoko Mochizuki, Satoshi Teramukai, Takahiko Tokuda, Toshiki Mizuno, Takashi Kasai

    Published 2024-01-01
    “…The Dementia Screening Questionnaire for Individuals with Intellectual Disabilities (DSQIID) is an appropriate screening tool for detecting dementia in Down's syndrome patients. However, whether this questionnaire reflects the neuropsychiatric signs of biomarker-confirmed Alzheimer's disease in DS (DS-AD) remains unknown. …”
    Get full text
    Article
  6. 46

    Design and Implementation of a Multinational Computerized Patient Survey: The European Paediatric Orthopaedic Society Down Syndrome Survey by David M. Steinberg, Moshe Kaplan, Joav Merrick, Shlomo Wientroub

    Published 2004-01-01
    “…In 1997, the European Paediatric Orthopaedic Society (EPOS) initiated an international survey of musculoskeletal problems in individuals with Down syndrome. The goals of the study were far-reaching and ambitious in order to obtain a clear picture of the variety of orthopedic problems associated with Down syndrome, to relate their occurrence to other medical conditions, and to record and compare methods of treatment. …”
    Get full text
    Article
  7. 47
  8. 48
  9. 49

    Evaluation of the Efficacy of Nasal Sedation Midazolam Compared with Dexmedetomidine in the Management of Uncooperative Children with Down Syndrome during Dental Treatment by Mohamad Nabil Hamod, Chaza Kouchaji, Faten Rostom, Hasan Alzoubi, Imad Katbeh, Nikolay Tuturov

    Published 2022-01-01
    “…This study aimed to compare the intranasal administration of midazolam and dexmedetomidine in uncooperative children with Down syndrome. Materials and Methods. The sample consisted of 20 children with Down syndrome aged 5 to 11 years who were divided equally into two groups: Group 1 (experimental) nasal dexmedetomidine and Group 2 (control) nasal midazolam. …”
    Get full text
    Article
  10. 50

    Down syndrome with cryptorchidism and retroperitoneal mixed germ cell tumour in an adult patient: a case report and literature review by Qiang Wang, Hai-bin Zhou, Li Ao, Yi Jiang, Xiao-Cong Zhou

    Published 2025-01-01
    “…Abstract Background An association between testicular cancer and Down syndrome has been reported by several studies. Down syndrome with cryptorchidism and retroperitoneal mixed germ cell tumours is rare, and yolk sac tumours are often considered secondary components of mixed germ cell tumours. …”
    Get full text
    Article
  11. 51
  12. 52
  13. 53
  14. 54
  15. 55
  16. 56

    Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome by Jonah J. Scott-McKean, Adriano L. Roque, Krystyna Surewicz, Mark W. Johnson, Witold K. Surewicz, Alberto C. S. Costa

    Published 2018-01-01
    “…The Ts65Dn mouse is the most studied animal model of Down syndrome. Past research has shown a significant reduction in CA1 hippocampal long-term potentiation (LTP) induced by theta-burst stimulation (TBS), but not in LTP induced by high-frequency stimulation (HFS), in slices from Ts65Dn mice compared with euploid mouse-derived slices. …”
    Get full text
    Article
  17. 57

    The implementation and impact of non-invasive prenatal testing (NIPT) for Down's syndrome into antenatal screening programmes: A systematic review and meta-analysis. by Elinor Sebire, Chithramali Hasanthika Rodrigo, Sohinee Bhattacharya, Mairead Black, Rachael Wood, Rute Vieira

    Published 2024-01-01
    “…<h4>Background</h4>Non-invasive prenatal testing (NIPT) is a widely adopted maternal blood test that analyses foetal originating DNA to screen for foetal chromosomal conditions, including Down's syndrome (DS). The introduction of this test, which may have implications for important decisions made during pregnancy, requires continual monitoring and evaluation. …”
    Get full text
    Article
  18. 58
  19. 59

    A Case-Control Study for Assessing Risk Factors for Congenital Anomalies among Children in Sulaimani City by Niaz Mustafa Kamal, Nasih Othman

    Published 2018-07-01
    Subjects: “…Sulaimani, Anomalies, Down syndrome, consanguinity, Microcephaly, Cleft lip.…”
    Get full text
    Article
  20. 60